BioSpace News Archive

Quantum communication infrastructure being developed in Europe

Intuitive’s new sealing instrument and its first generator add versatility

A live broadcast will be available by visiting the Investor Relations section of Theravance Biopharma’s website at www.theravance.com

A live webcast of the presentation will be available on the Company’s website at www.herontx.com in the Investor Resources section.

The live presentation will be webcast and may be accessed on the Company’s website under Investors at www.neurocrine.com

Patients who have never used a modulator are more likely to say CF negatively impacts their overall quality of life

These results showed that, even at the lowest dose of hydromethylthionine previously tested in two Phase 3 global clinical trials (8 mg/day), the drug produced concentration-dependent effects on cognitive decline and brain atrophy.

A fully integrated specialty biopharmaceutical company, it focuses exclusively on the development and manufacture of high-quality biosimilar products.

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases, today announced that company management will participate at the Evercore ISI 2nd Annual HealthCONx Conference

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today its results for the third quarter ended September 30, 2019 and provided an update on recent corporate developments.